Bumetanide nasal spray - Corstasis Therapeutics
Alternative Names: RSQ-777-02Latest Information Update: 24 Feb 2025
At a glance
- Originator Corstasis Therapeutics
- Class Antihypertensives; Antiparkinsonians; Behavioural disorder therapies; Benzoic acids; Heart failure therapies; Sulfonamides; Vascular disorder therapies
- Mechanism of Action Sodium-potassium-chloride symporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Oedema